The Drug-Induced Respiratory Disease Website and App

Neuromuscular blocking agents (NMBA-NMBD)

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

V.b

Eosinophilic pleural effusion

Publications

Moufarrege G, Frank E, Carstens DD

Eosinophilic exudative pleural effusion after initiation of tizanidine treatment: a case report.

Pain medicine (Malden, Mass.). 2003;4(1):85-90

Petusevsky ML, Faling LJ, Rocklin RE, Snider GL, Merliss AD, Moses JM, Dorman SA

Pleuropericardial reaction to treatment with dantrolene.

JAMA. 1979;242(25):2772-4